We are live on ! Find out more
BDR

Blonder Tongue Laboratories Inc

Delisted

BDR was delisted on the 24th of June, 2022.

7 hedge funds and large institutions have $332K invested in Blonder Tongue Laboratories Inc in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more capital invested

Capital invested by funds: $280K → $332K (+$52K)

0% more funds holding

Funds holding: 77 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
7
Holders Change
Holders Change %
0%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change

BDR Hedge Fund Activity: Q4 2019 in Review

7 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Blonder Tongue Laboratories Inc (BDR) for Q4 2019, worth a combined $332K — up 19% from $280K a quarter earlier.

Fund positioning in BDR was balanced in Q4 2019: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 2 trimmed.

The largest buyer was Cambridge Trust, opening a new position worth an estimated $8.87K. The largest seller was UBS Group, cutting an estimated $2.76K.

  • 7 institutional investors held Blonder Tongue Laboratories Inc (BDR) as of Q4 2019, unchanged from Q3 2019.
  • Funds reported $332K of Blonder Tongue Laboratories Inc stock for Q4 2019, up 19% quarter-over-quarter.
  • 1 fund opened new Blonder Tongue Laboratories Inc positions in Q4 2019 and 1 closed out, a net change of 0 holders.
  • The largest Blonder Tongue Laboratories Inc buyer in Q4 2019 was Cambridge Trust, an estimated $8.87K added.
  • The largest Blonder Tongue Laboratories Inc seller in Q4 2019 was UBS Group, an estimated $2.76K sold.

Based on aggregated 13F filings for Q4 2019.